Joint Preservation Therapy Solutions in Hartford, CT

CDC PLACES vs. JK: two files, not one brochure

Adult obesity in Hartford is 40.4% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 15.8% of adults in Hartford have diagnosed diabetes — 3.8 points above the U.S. 12% figure. Connecticut is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for joint preservation therapy, not a walk-in clinic.

Where Hartford programs actually stall

• Adult arthritis here is 23.1% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 20.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Connecticut.
• JK (National Government Services (NGS)) is the contractor that will review CTP units, application frequency, and wound measurements for Connecticut Part B claims. Practices that skip MAC education typically see denials before they see outcomes.
• Connecticut is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).

Uninsured mix and Medicare CTPs in the same building

America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Hartford we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 15.8% of adults in Hartford have diagnosed diabetes — 3.8 points above the U.S. 12% figure.

How we’d stand this up in clinic